Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
CURRENT ASSETS
Cash and cash equivalents	$ 14,917	$ 97,205
Total current assets	14,917	97,205
Cryptocurrency	18,519	123,794
TOTAL ASSETS	33,436	220,999
CURRENT LIABILITIES
Accounts payable and accrued expenses	4,386,896	3,876,849
Other liabilities	207,938	207,938
Notes payable	1,504,141	533,670
Derivative liability	2,487	563,417
Convertible debt	38,772	1,125,673
Total current liabilities	6,140,234	6,307,546
Notes payable - other	11,799	11,976
TOTAL LIABILITIES	6,152,033	6,319,522
STOCKHOLDERS’ DEFICIT
Preferred A voting stock, $0.001 par value; 10 shares authorized 10 and -0- shares issued and outstanding, respectively, as of March 31, 2026 and December 31, 2025, respectively
Common stock, $0.001 par value; 19,000,000,000 shares authorized 5,210,040,623 and 5,058,291,867 shares issued and outstanding, respectively, as of March 31, 2026 and December 31, 2025, respectively.	5,210,039	5,058,291
Additional paid-in-capital	45,550,140	45,550,140
Accumulated deficit	(56,878,776)	(56,706,954)
TOTAL STOCKHOLDERS’ DEFICIT	(6,118,598)	(6,098,523)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$ 33,436	$ 220,999

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.